Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BR55 Ultrasound Molecular Imaging Dose-Finding Study
CTR20220634Phase 2Completed
- Sponsor
- Bracco S.p.A.
- Start
- Mar 2022
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of perfluorobutane/nitrogen lipopeptide-coated microbubbles in breast cancer, ovarian cancer, thyroid cancer, inflammatory bowel disease (IBD), rheumatoid arthritis (RA), sponsored by Bracco S.p.A.. Started Mar 2022; status: completed.
02
Drugs
perfluorobutane/nitrogen lipopeptide-coated microbubbles
03
Conditions
breast cancerovarian cancerthyroid cancerinflammatory bowel disease (IBD)rheumatoid arthritis (RA)
Beyond the preview
Go deeper on CTR20220634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220634.